LIVNLivaNova PLCHealthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $78.51 · now $78.51 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, LIVN has typically landed between $66.12 and $91.48 — a range of −15.8% to +16.5% from the issuance price $78.51.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

2,722 overlapping 1 month windows · 2015-10-192026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($78.51) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where LIVN has typically landed a month from the 2026-09-16 close of $78.51 — the range is history, not a prediction.

$66.12worst · -15.8%$91.48best · +16.5%
  • now $78.51 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $78.75 (+0.3%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $73.44$84.06
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $66.12$91.48
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,722 windows spanning 2015-10-19 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-21−51.5%−51.5%+8.4%
2020-02-20−48.0%−48.0%+8.7%
2020-03-04−44.9%−55.3%+0.0%
3 best
2020-03-23+40.9%+0.0%+48.5%
2025-08-01+38.4%+0.0%+38.4%
2020-11-20+38.4%+0.0%+38.4%

2,722 overlapping windows · 2015-10-192026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~11 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
55%
−0.9%
n=11
Feb
82%
+2.7%
n=11
Mar
27%
−5.6%
n=11
Apr
45%
+0.1%
n=11
May
64%
+3.7%
n=11
Jun
73%
+1.9%
n=11
Jul
55%
+1.5%
n=11
Aug
64%
+4.4%
n=11
Sep
27%
−1.9%
n=11
Oct
30%
−2.2%
n=10
Nov
64%
+3.3%
n=11
Dec
45%
+0.7%
n=11

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$85$502026-09-10: 1 insider sale, $273K — Bianchi Francesco2026-09-04: 1 insider sale, $187K — Story Brooke2026-08-31: 1 insider sale, $132K — Bianchi Francesco2026-08-11: 1 insider sale, $208K — Tezel Ahmet2026-06-15: 1 insider sale, $96K — Bianchi Francesco2026-05-26: 1 insider sale, $136K — Bianchi Francesco2025-11-18: 1 insider sale, $13K — Story Brooke2025-08-25: 1 insider sale, $85K — Bianchi Francesco2025-08: 1 open-market sale, $85K2025-11: 1 open-market sale, $13K2026-05: 1 open-market sale, $136K2026-06: 1 open-market sale, $96K2026-08: 2 open-market sales, $339K2026-09: 2 open-market sales, $460K↑ buys↓ salesdirector Bianchi Francesco — Sale on 2026-09-10, filed 4 days after the tradedirector Story Brooke — Sale on 2026-09-04, filed 4 days after the tradedirector Bianchi Francesco — Sale on 2026-08-31, filed 2 days after the tradeofficer Tezel Ahmet — Sale on 2026-08-11, filed 2 days after the tradedirector Bianchi Francesco — Sale on 2026-06-15, filed 2 days after the tradedirector Bianchi Francesco — Sale on 2026-05-26, filed 1 day after the tradedirector Story Brooke — Sale on 2025-11-18, filed 1 day after the tradedirector Bianchi Francesco — Sale on 2025-08-25, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-10Bianchi FrancescodirectorSale3,500 @ $78.01$273K−44.1% of holdingnot yet — horizon still opennot yet — horizon still open4,434Form 4 · filed 4 days after the trade
2026-09-04Story BrookedirectorSale2,300 @ $81.42$187K−23.5% of holdingnot yet — horizon still opennot yet — horizon still open7,488Form 4 · filed 4 days after the trade
2026-08-31Bianchi FrancescodirectorSale1,650 @ $79.72$132K−17.2% of holdingnot yet — horizon still opennot yet — horizon still open7,934Form 4 · filed 2 days after the trade
2026-08-11Tezel AhmetofficerSale2,675 @ $77.74$208K−30.5% of holding+1.1%not yet — horizon still open6,090Form 4 · filed 2 days after the trade
2026-06-15Bianchi FrancescodirectorSale1,200 @ $80.19$96K−11.1% of holding+2.9%not yet — horizon still open9,584Form 4 · filed 2 days after the trade
2026-05-26Bianchi FrancescodirectorSale1,800 @ $75.75$136K−19.9% of holding+9.4%not yet — horizon still open7,228Form 4 · filed 1 day after the trade
2025-11-18Story BrookedirectorSale250 @ $53.94$13K−3.9% of holding+12.7%+23.5%6,232Form 4 · filed 1 day after the trade
2025-08-25Bianchi FrancescodirectorSale1,500 @ $56.50$85K−14.2% of holding−8.7%+16.2%9,028Form 4 · filed 2 days after the trade
2024-12-11Bianchi FrancescodirectorSale1,250 @ $50.99$64K−14.2% of holding−3.7%−11.5%7,522Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

214 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-15Liddy Anne M.officerAward / grant6,2916,291Form 4
2026-08-11Tezel AhmetofficerDisposition8,58910,193Form 4
2026-08-11Tezel AhmetofficerOption exercise12,69218,782Form 4
2026-08-11Tezel AhmetofficerWithheld for tax1,4288,765Form 4
2026-08-11Tezel AhmetofficerOption exercise12,69212,691Form 4
2026-06-15Tezel AhmetofficerWithheld for tax1,0326,090Form 4
2026-06-15KOZY WILLIAM AdirectorWithheld for tax68237,566Form 4
2026-06-15Enxing Seng StacydirectorWithheld for tax48615,307Form 4
2026-06-15PODLOGAR SUSAN MdirectorWithheld for tax4865,642Form 4
2026-06-15Barry James ChristopherdirectorWithheld for tax4867,918Form 4
2026-06-15SCHERMERHORN TODD CdirectorWithheld for tax48612,619Form 4
2026-06-15Bianchi FrancescodirectorWithheld for tax48610,784Form 4
2026-06-15Story BrookedirectorWithheld for tax4869,788Form 4
2026-06-15WILVER PETER MdirectorWithheld for tax48610,294Form 4
2026-06-15Zurbay DonalddirectorWithheld for tax3082,252Form 4
2026-06-15Tezel AhmetofficerOption exercise2,9655,931Form 4
2026-06-15PODLOGAR SUSAN MdirectorOption exercise4,0426,128Form 4
2026-06-15PODLOGAR SUSAN MdirectorOption exercise4,0420Form 4
2026-06-15PODLOGAR SUSAN MdirectorAward / grant2,3832,383Form 4
2026-06-15SCHERMERHORN TODD CdirectorOption exercise4,04213,105Form 4
2026-06-15SCHERMERHORN TODD CdirectorOption exercise4,0420Form 4
2026-06-15SCHERMERHORN TODD CdirectorAward / grant2,3832,383Form 4
2026-06-15WILVER PETER MdirectorOption exercise4,04210,780Form 4
2026-06-15WILVER PETER MdirectorOption exercise4,0420Form 4
2026-06-15WILVER PETER MdirectorAward / grant2,3832,383Form 4
2026-06-15Story BrookedirectorOption exercise4,0420Form 4
2026-06-15Barry James ChristopherdirectorOption exercise4,0428,404Form 4
2026-06-15Barry James ChristopherdirectorOption exercise4,0420Form 4
2026-06-15Barry James ChristopherdirectorAward / grant2,3832,383Form 4
2026-06-15Bianchi FrancescodirectorOption exercise4,04211,270Form 4
2026-06-15Bianchi FrancescodirectorOption exercise4,0420Form 4
2026-06-15Bianchi FrancescodirectorAward / grant2,3832,383Form 4
2026-06-15Enxing Seng StacydirectorOption exercise4,04215,793Form 4
2026-06-15Enxing Seng StacydirectorOption exercise4,0420Form 4
2026-06-15Enxing Seng StacydirectorAward / grant2,3832,383Form 4
2026-06-15KOZY WILLIAM AdirectorOption exercise5,68138,248Form 4
2026-06-15KOZY WILLIAM AdirectorOption exercise5,6810Form 4
2026-06-15KOZY WILLIAM AdirectorAward / grant2,3832,383Form 4
2026-06-15Zurbay DonalddirectorOption exercise2,5602,560Form 4
2026-06-15Zurbay DonalddirectorOption exercise2,5600Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.